Literature DB >> 34985847

Comparing Published Gut Microbiome Taxonomic Data Across Multinational Studies.

Brianna K Meeks, Katherine A Maki, Nancy J Ames, Jennifer J Barb.   

Abstract

BACKGROUND: Nurse researchers are well poised to study the connection of the microbiome to health and disease. Evaluating published microbiome results can assist with study design and hypothesis generation.
OBJECTIVES: This article aims to present and define important analysis considerations in microbiome study planning and to identify genera shared across studies despite methodological differences. This methods article will highlight a workflow that the nurse scientist can use to combine and evaluate taxonomy tables for microbiome study or research proposal planning.
METHODS: We compiled taxonomy tables from 13 published gut microbiome studies that had used Ion Torrent sequencing technology. We searched for studies that had amplified multiple hypervariable (V) regions of the 16S rRNA gene when sequencing the bacteria from healthy gut samples.
RESULTS: We obtained 15 taxonomy tables from the 13 studies, comprised of samples from four continents and eight V regions. Methodology among studies was highly variable, including differences in V regions amplified, geographic location, and population demographics. Nevertheless, of the 354 total genera identified from the 15 data sets, 25 were shared in all V regions and the four continents. When relative abundance differences across the V regions were compared, Dorea and Roseburia were statistically different. Taxonomy tables from Asian subjects had increased average abundances of Prevotella and lowered abundances of Bacteroides compared with the European, North American, and South American study subjects. DISCUSSION: Evaluating taxonomy tables from previously published literature is essential for study planning. The genera found from different V regions and continents highlight geography and V region as important variables to consider in microbiome study design. The 25 shared genera across the various studies may represent genera commonly found in healthy gut microbiomes. Understanding the factors that may affect the results from a variety of microbiome studies will allow nurse scientists to plan research proposals in an informed manner. This work presents a valuable framework for future cross-study comparisons conducted across the globe.
Copyright © 2021 Wolters Kluwer Health, Inc. All rights reserved.

Entities:  

Mesh:

Year:  2022        PMID: 34985847      PMCID: PMC8740627          DOI: 10.1097/NNR.0000000000000557

Source DB:  PubMed          Journal:  Nurs Res        ISSN: 0029-6562            Impact factor:   2.381


  43 in total

1.  Considerations When Designing a Microbiome Study: Implications for Nursing Science.

Authors:  Katherine A Maki; Ana F Diallo; Mark B Lockwood; Alexis T Franks; Stefan J Green; Paule V Joseph
Journal:  Biol Res Nurs       Date:  2018-11-08       Impact factor: 2.522

Review 2.  Roseburia spp.: a marker of health?

Authors:  Zohreh Tamanai-Shacoori; Imen Smida; Latifa Bousarghin; Olivier Loreal; Vincent Meuric; Shao Bing Fong; Martine Bonnaure-Mallet; Anne Jolivet-Gougeon
Journal:  Future Microbiol       Date:  2017-02       Impact factor: 3.165

Review 3.  Action and function of Faecalibacterium prausnitzii in health and disease.

Authors:  Carmen Veríssima Ferreira-Halder; Alessandra Valéria de Sousa Faria; Sheila Siqueira Andrade
Journal:  Best Pract Res Clin Gastroenterol       Date:  2017-09-18       Impact factor: 3.043

4.  Reclassification of Eubacterium formicigenerans Holdeman and Moore 1974 as Dorea formicigenerans gen. nov., comb. nov., and description of Dorea longicatena sp. nov., isolated from human faeces.

Authors:  David Taras; Rainer Simmering; Matthew D Collins; Paul A Lawson; Michael Blaut
Journal:  Int J Syst Evol Microbiol       Date:  2002-03       Impact factor: 2.747

5.  The neuroactive potential of the human gut microbiota in quality of life and depression.

Authors:  Sara Vieira-Silva; Jeroen Raes; Mireia Valles-Colomer; Gwen Falony; Youssef Darzi; Ettje F Tigchelaar; Jun Wang; Raul Y Tito; Carmen Schiweck; Alexander Kurilshikov; Marie Joossens; Cisca Wijmenga; Stephan Claes; Lukas Van Oudenhove; Alexandra Zhernakova
Journal:  Nat Microbiol       Date:  2019-02-04       Impact factor: 17.745

6.  Molecular Characterization and Meta-Analysis of Gut Microbial Communities Illustrate Enrichment of Prevotella and Megasphaera in Indian Subjects.

Authors:  Shrikant Bhute; Pranav Pande; Sudarshan A Shetty; Rahul Shelar; Sachin Mane; Shreyas V Kumbhare; Ashwini Gawali; Hemal Makhani; Mohit Navandar; Dhiraj Dhotre; Himangi Lubree; Dhiraj Agarwal; Rutuja Patil; Shantanu Ozarkar; Saroj Ghaskadbi; Chittaranjan Yajnik; Sanjay Juvekar; Govind K Makharia; Yogesh S Shouche
Journal:  Front Microbiol       Date:  2016-05-09       Impact factor: 5.640

7.  Basal Diet Determined Long-Term Composition of the Gut Microbiome and Mouse Phenotype to a Greater Extent than Fecal Microbiome Transfer from Lean or Obese Human Donors.

Authors:  Daphne M Rodriguez; Abby D Benninghoff; Niklas D J Aardema; Sumira Phatak; Korry J Hintze
Journal:  Nutrients       Date:  2019-07-17       Impact factor: 5.717

Review 8.  Defining the human microbiome.

Authors:  Luke K Ursell; Jessica L Metcalf; Laura Wegener Parfrey; Rob Knight
Journal:  Nutr Rev       Date:  2012-08       Impact factor: 7.110

9.  Development of an Analysis Pipeline Characterizing Multiple Hypervariable Regions of 16S rRNA Using Mock Samples.

Authors:  Jennifer J Barb; Andrew J Oler; Hyung-Suk Kim; Natalia Chalmers; Gwenyth R Wallen; Ann Cashion; Peter J Munson; Nancy J Ames
Journal:  PLoS One       Date:  2016-02-01       Impact factor: 3.240

10.  Gut Microbiota and Predicted Metabolic Pathways in a Sample of Mexican Women Affected by Obesity and Obesity Plus Metabolic Syndrome.

Authors:  Alejandra Chávez-Carbajal; Khemlal Nirmalkar; Ana Pérez-Lizaur; Fernando Hernández-Quiroz; Silvia Ramírez-Del-Alto; Jaime García-Mena; César Hernández-Guerrero
Journal:  Int J Mol Sci       Date:  2019-01-21       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.